Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis
Fibrinogen-like 2 (FGL2) was recently found to be associated with fibrosis in a mouse model of kidney damage and was proposed as a potential therapeutic target in chronic kidney disease (CKD). We assessed the association of renal FGL2 mRNA expression with the disease outcome in two independent CKD c...
Main Authors: | Sara Denicolò, Viji Nair, Johannes Leierer, Michael Rudnicki, Matthias Kretzler, Gert Mayer, Wenjun Ju, Paul Perco |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/13/1/89 |
Similar Items
-
Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target
by: Wenjing Qian, et al.
Published: (2021-09-01) -
The Role of FGL2 in the Pathogenesis and Treatment of Hepatitis C Virus Infection
by: Nazia Selzner, et al.
Published: (2010-07-01) -
Targeting FGL2 in glioma immunosuppression and malignant progression
by: Xiaoyu Ma, et al.
Published: (2022-10-01) -
Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1–FGL1–MYH9 axis
by: Xi-Yang Tang, et al.
Published: (2022-10-01) -
FGL2 is positively correlated with enhanced antitumor responses mediated by T cells in lung adenocarcinoma
by: Kai Yuan, et al.
Published: (2020-03-01)